Suppr超能文献

溴苄铵和胍乙啶在神经肌肉接头处的作用。

Action of bretylium and guanethidine at the neuromuscular junction.

作者信息

DIXIT B N, GULATI O D, GOKHALE S D

出版信息

Br J Pharmacol Chemother. 1961 Dec;17(3):372-9. doi: 10.1111/j.1476-5381.1961.tb01123.x.

Abstract

Bretylium and guanethidine produced a block of neuromuscular transmission in the rat phrenic nerve diaphragm and cat sciatic gastrocnemius preparations, but had a potentiating effect on acetylcholine-induced contracture of the frog rectus. On the sciatic gastrocnemius preparation of the cat the compounds had a twofold action, consisting of an initial transient, and a delayed but more sustained, block of neuromuscular transmission. Bretylium and guanethidine had no immediate effect on the response of the muscle to direct stimulation, though a weak delayed depressant effect was observed. Intravenous injection of these compounds produced a flaccid paralysis in pigeons. Possible mechanisms of the neuromuscular blocking action of bretylium and guanethidine are discussed. Inhibition of acetylcholine release from motor nerve endings resulting from local anaesthesia by these compounds is suggested as a possible mechanism of their neuromuscular blocking action.

摘要

溴苄铵和胍乙啶可阻断大鼠膈神经膈肌及猫坐骨神经腓肠肌标本的神经肌肉传递,但对乙酰胆碱诱导的青蛙腹直肌挛缩有增强作用。在猫的坐骨神经腓肠肌标本上,这些化合物有双重作用,包括最初的短暂阻断以及延迟但更持久的神经肌肉传递阻断。溴苄铵和胍乙啶对肌肉直接刺激的反应无即时作用,不过观察到有微弱的延迟抑制效应。静脉注射这些化合物可使鸽子出现弛缓性麻痹。文中讨论了溴苄铵和胍乙啶神经肌肉阻断作用的可能机制。这些化合物通过局部麻醉抑制运动神经末梢乙酰胆碱释放被认为是其神经肌肉阻断作用的一种可能机制。

相似文献

1
Action of bretylium and guanethidine at the neuromuscular junction.
Br J Pharmacol Chemother. 1961 Dec;17(3):372-9. doi: 10.1111/j.1476-5381.1961.tb01123.x.
2
Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.
Br J Pharmacol Chemother. 1962 Feb;18(1):161-6. doi: 10.1111/j.1476-5381.1962.tb01159.x.
4
Effects of diacetyl monoxime on neuromuscular transmission.
Br J Pharmacol Chemother. 1959 Sep;14(3):317-22. doi: 10.1111/j.1476-5381.1959.tb00250.x.
6
The action of substances which block sympathetic postganglionic nervous transmission.
Br J Pharmacol Chemother. 1963 Apr;20(2):378-87. doi: 10.1111/j.1476-5381.1963.tb01476.x.
7
Supersensitivity of salivary glands following treatment with bretylium or guanethidine.
Br J Pharmacol Chemother. 1961 Jun;16(3):315-9. doi: 10.1111/j.1476-5381.1961.tb01090.x.
8
Effect of guanethidine and bretylium on the dog heart-lung preparation.
Circ Res. 1961 Jan;9:83-8. doi: 10.1161/01.res.9.1.83.
9
Tissue amine levels and sympathetic blockade after guanethidine and bretylium.
Br J Pharmacol Chemother. 1961 Dec;17(3):442-50. doi: 10.1111/j.1476-5381.1961.tb01131.x.
10

引用本文的文献

1
THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS.
Br J Pharmacol Chemother. 1964 Dec;23(3):486-507. doi: 10.1111/j.1476-5381.1964.tb01605.x.
2
THE SYMPATHETIC POSTGANGLIONIC FIBRE AND THE BLOCK BY BRETYLIUM; THE BLOCK PREVENTED BY HEXAMETHONIUM AND IMITATED BY MECAMYLAMINE.
Br J Pharmacol Chemother. 1964 Jun;22(3):549-57. doi: 10.1111/j.1476-5381.1964.tb01709.x.
3
The action of substances which block sympathetic postganglionic nervous transmission.
Br J Pharmacol Chemother. 1963 Apr;20(2):378-87. doi: 10.1111/j.1476-5381.1963.tb01476.x.
4
Guanethidine after twenty years: a pharmacologist's perspective.
Br J Clin Pharmacol. 1982 Jan;13(1):35-44. doi: 10.1111/j.1365-2125.1982.tb01334.x.
5
The effect of calcium in removing the blocking action of bretylium and guanethidine.
Br J Pharmacol Chemother. 1967 Sep;31(1):74-81. doi: 10.1111/j.1476-5381.1967.tb01978.x.
6
Blockade of adrenergic and cholinergic transmissions by emetine.
Br J Pharmacol Chemother. 1966 Nov;28(2):228-37. doi: 10.1111/j.1476-5381.1966.tb01889.x.
7
Effects of adrenergic neurone blocking agents on voluntary muscle stimulated at different frequencies.
Br J Pharmacol Chemother. 1966 May;27(1):164-76. doi: 10.1111/j.1476-5381.1966.tb01652.x.
8
Release of noradrenaline from the sympathetic postganglionic fibre.
Br Med J. 1967 Apr 22;2(5546):197-201. doi: 10.1136/bmj.2.5546.197.
9
[On veno-vasomotor vascular reactions in the mesenteric circulation of cats].
Pflugers Arch Gesamte Physiol Menschen Tiere. 1966;287(4):330-44.
10
Actions of bretylium tosylate at the neuromuscular junction.
Br J Pharmacol. 1971 Apr;41(4):607-21. doi: 10.1111/j.1476-5381.1971.tb07069.x.

本文引用的文献

2
Comparison of bretylium tosylate with guanethidine in the treatment of severe hypertension.
Lancet. 1960 Aug 20;2(7147):387-9. doi: 10.1016/s0140-6736(60)92837-3.
3
The actions of bretylium: adrenergic neurone blocking and other effects.
Br J Pharmacol Chemother. 1959 Dec;14(4):536-48. doi: 10.1111/j.1476-5381.1959.tb00961.x.
4
Some pharmacological actions of bretylium and guanethidine.
Lancet. 1960 Oct 8;2(7154):787-8. doi: 10.1016/s0140-6736(60)91856-0.
5
The prolonged use of guanethidine.
Med Clin North Am. 1961 Mar;45:417-20. doi: 10.1016/s0025-7125(16)33903-7.
6
The use of bretylium tosylate (Darenthin) in hypertension.
Med Clin North Am. 1961 Mar;45:429-39. doi: 10.1016/s0025-7125(16)33905-0.
7
Muscle weakness caused by bretylium tosylate.
Lancet. 1960 Oct 8;2(7154):789. doi: 10.1016/s0140-6736(60)91857-2.
8
The effect of lowered muscle temperature on the action of neuromuscular blocking drugs.
J Physiol. 1958 May 28;141(3):425-34. doi: 10.1113/jphysiol.1958.sp005986.
10
The methonium.
Pharmacol Rev. 1952 Sep;4(3):219-53.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验